Patients with mutations in TBX4 present with severe PAH associated with bronchial and parenchymal changes, low DLCO, with or without skeletal abnormalities [142], and bimodal age of onset [25]. The gene discussed is TBX4; the disease is pulmonary arterial hypertension.